FIGURE 1.
Proportion of COVID‐19 hospitalizations with administration of select medications, by week, February 20, 2020‐January 10, 2021, HCA Healthcare Sentinel System data. The gray bars represent COVID‐19 hospitalizations independent of medication administrations. The US Food and Drug Administration issued an emergency use authorization (EUA) for remdesivir on May 1, 2020. 26 Preliminary results from the RECOVERY trial on dexamethasone were released June 16, 2020 27 [Colour figure can be viewed at wileyonlinelibrary.com]